NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zealand Pharma A/S (PINK: ZLDPF)

 
ZLDPF Technical Analysis
5
As on 6th Mar 2026 ZLDPF STOCK Price closed @ 40.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 60.01 & Strong Sell for SHORT-TERM with Stoploss of 87.52 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZLDPFSTOCK Price

Open 37.50 Change Price %
High 40.00 1 Day -17.67 -30.64
Low 36.54 1 Week -27.28 -40.55
Close 40.00 1 Month -37.78 -48.57
Volume 19485 1 Year -60.09 -60.04
52 Week High 110.00 | 52 Week Low 40.00
 
PINK USA Most Active Stocks
ECOX 0.00 %
VNUE 0.00 %
HMBL 0.00 %
SPOM 0.00 %
TXGE 3316.21 2.69%
GTVH 0.00 %
HIRU 0.00 %
AITX 0.00 %
SUTI 0.00 %
LTNC 0.00 %
 
PINK USA Top Gainers Stocks
GLOH 3.75 37400.00%
ANAV 12.05 30025.00%
CEBUF 1.69 16800.00%
DLEXY 1.55 15400.00%
RMIAF 0.87 8600.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
GPGC 0.40 3900.00%
WMTN 1.00 900.00%
OGGNF 0.10 900.00%
 
PINK USA Top Losers Stocks
GMETF 0.27 -100.00%
GMETF 0.27 -100.00%
IRNS 0.00 -100.00%
AURWF 0.00 -100.00%
EZOO 0.00 -100.00%
IZCFF 0.00 -100.00%
FTRS 0.00 -100.00%
XITO 0.00 -100.00%
BHCCF 0.00 -100.00%
VADP 0.00 -100.00%
 
 
ZLDPF
Daily Charts
ZLDPF
Intraday Charts
Whats New @
Bazaartrend
ZLDPF
Free Analysis
 
ZLDPF Important Levels Intraday
RESISTANCE46.67
RESISTANCE44.53
RESISTANCE43.21
RESISTANCE41.89
SUPPORT38.11
SUPPORT36.79
SUPPORT35.47
SUPPORT33.33
 
ZLDPF Forecast March 2026
4th UP Forecast113.23
3rd UP Forecast89.74
2nd UP Forecast75.23
1st UP Forecast60.71
1st DOWN Forecast19.29
2nd DOWN Forecast4.77
3rd DOWN Forecast-9.74
4th DOWN Forecast-33.23
 
ZLDPF Weekly Forecast
4th UP Forecast58.79
3rd UP Forecast52.76
2nd UP Forecast49.04
1st UP Forecast45.31
1st DOWN Forecast34.69
2nd DOWN Forecast30.96
3rd DOWN Forecast27.24
4th DOWN Forecast21.21
 
ZLDPF Forecast2026
4th UP Forecast181.56
3rd UP Forecast136.16
2nd UP Forecast108.1
1st UP Forecast80.04
1st DOWN Forecast-0.04
2nd DOWN Forecast-28.1
3rd DOWN Forecast-56.16
4th DOWN Forecast-101.56
 
 
ZLDPF Other Details
Segment EQ
Market Capital 1372448384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ZLDPF Address
ZLDPF
 
ZLDPF Latest News
 
Your Comments and Response on Zealand Pharma A/S
 
ZLDPF Business Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Address: Sydmarken 11, Copenhagen, Denmark, 2860
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service